Ledger.Open graph →
SEC Form D · filed April 13, 2023

GENEOS Therapeutics, Inc

Offering
$10.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PLYMOUTH MEETING, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Niranjan Y. Sardesai · Plymouth Meeting, PAExec · DirectorCasey Y. Cunningham · Plymouth Meeting, PADirectorSangwoo Y. Lee · Plymouth Meeting, PADirectorSamuel Y. Broder · Plymouth Meeting, PADirectorTed Y. Fjallman · Plymouth Meeting, PADirectorJames Y. Eadie · Plymouth Meeting, PADirectorRichard S. Eiswirth, Jr · Alpharetta, GADirectorRussell S. Skibsted · Alpharetta, GAExec · DirectorDavid S. Holland · Alpharetta, GADirectorErin R. Parsons · Alpharetta, GADirectorJohn J. Snisarenko · Alpharetta, GADirectorLaurent Y. Humeau · Plymouth Meeting, PADirectorEric Chapman · Cumberland, MEDirectorBeth Gusenoff · Pittsburgh, PADirectorDenise Gottfried · Woodside, CADirectorJeffrey Gusenoff · Pittsburgh, PAExec · DirectorSanjay Dhir · CARSON CITY, NVDirectorLaurent Y. Humeau · Plymouth Meeting, PADirectorJames Y. Eadie · Plymouth Meeting, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗